Phase II clinical experience with the proteasome inhibitor bortezomib (formerly PS-341) in patients with indolent lymphoma

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570572700095757824
  • NII Article ID
    10013081866
  • Data Source
    • CiNii Articles

Report a problem

Back to top